MTEMQ (Molecular Templates) Other Current Liabilities: $2.64 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTEMQ Molecular Templates Inc MTEMQ
12 GF Score
Price $0.00
View Full Analysis

What is Molecular Templates Other Current Liabilities?

Molecular Templates MTEMQ 12 Other Current Liabilities is $2.64 Mil as of Jun. 2024. GuruFocus rates MTEMQ with a GF Score™ of 12/100.

Molecular Templates's other current liabilities for the quarter that ended in Jun. 2024 was $2.64 Mil.

Molecular Templates's quarterly other current liabilities increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($3.15 Mil) but then declined from Mar. 2024 ($3.15 Mil) to Jun. 2024 ($2.64 Mil).

Molecular Templates's annual other current liabilities declined from Dec. 2021 ($2.61 Mil) to Dec. 2022 ($2.18 Mil) and declined from Dec. 2022 ($2.18 Mil) to Dec. 2023 ($0.00 Mil).

Molecular Templates Other Current Liabilities Related Terms

Molecular Templates Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Molecular Templates's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Templates Other Current Liabilities Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 7.83 2.61 2.18 0.00

Molecular Templates Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 3.15 2.64
MTEMQ
12GF Score
Molecular Templates Inc MTEMQ
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecular Templates Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $2.64 Mil mean?
Molecular Templates (MTEMQ) has a Other Current Liabilities of $2.64 Mil as of Jun. 2024. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Molecular Templates.
Is Molecular Templates' Other Current Liabilities too high?
Molecular Templates' current Other Current Liabilities is $2.64 Mil. Overall, Molecular Templates has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Molecular Templates' Other Current Liabilities compare to GRTSQ and ARTHQ?
Molecular Templates' Other Current Liabilities of $2.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Molecular Templates. Molecular Templates's current Other Current Liabilities is $2.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecular Templates stock overvalued right now?
Molecular Templates (MTEMQ) has a current Other Current Liabilities of $2.64 Mil. The current Other Current Liabilities is $2.64 Mil. Molecular Templates' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Molecular Templates (MTEMQ), the current Other Current Liabilities is $2.64 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecular Templates Business Description

Address 9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
12GF Score

Get the complete analysis for MTEMQ

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price